Search results for "pneumonia."

showing 10 items of 651 documents

P343 Procalcitonin role in the management of lower respiratory tract infections in preschool children

2017

Introduction One of the major advantage of procalcitonin compared to other parameters is its highly and early increase in response to bacterial infection. The increased procalcitonin levels can be observed 3 to 6 hours after infectious challenge. It is a parameter that made a significant contribution to the clinical diagnosis, severity of infection and in the same time procalcitonin kinetics cand be used to assess the effectiveness of treatment. Methods A single- centre observational study consecutively enrolled 70 preschool children with lower respiratory tract infections who were hospitalised in Paediatric Clinic Hospital of Sibiu between January 2013 and January 2017. Procalcitonin, were…

medicine.medical_specialtyPaediatric clinicRespiratory tract infectionsmedicine.drug_classbusiness.industryAntibioticsBronchopneumoniamedicine.diseaseProcalcitoninClinical diagnosisInternal medicinemedicineObservational studybusinessIntensive care medicineHospital stayPosters
researchProduct

Iatrogenic pulmonary lesions.

2018

Treatment of patients often includes the administration of medications and sometimes radiation. While the intent is to treat an underlying condition, in some cases, adverse effects occur due to these agents. Most of these adverse effects are mild, however, some can be severe and life-threatening. Furthermore, while these effects are often reversible upon cessation of exposure, especially if the inciting agent is recognized and withdrawn early, others might be permanent or even progressing. Most common histopathologic findings in drug-induced interstitial lung disease include nonspecific interstitial pneumonia (cellular and/or fibrotic), organizing pneumonia with or without bronchiolitis, eo…

medicine.medical_specialtyPathologyDrug-Related Side Effects and Adverse ReactionsPolymersIatrogenic DiseaseAmiodaroneAntineoplastic Agents030204 cardiovascular system & hematologyPathology and Forensic Medicine03 medical and health sciences0302 clinical medicineEarly Medical InterventionmedicineEosinophilic pneumoniaHumansImmunologic FactorsIntensive care medicineDiffuse alveolar damageAdverse effectLungLungRadiotherapybusiness.industryInterstitial lung diseasePulmonary edemamedicine.diseasemedicine.anatomical_structureEquipment and SuppliesNitrofurantoin030220 oncology & carcinogenesisPulmonary hemorrhagebusinessLung Diseases InterstitialAnti-Arrhythmia AgentsHydrophobic and Hydrophilic InteractionsHypersensitivity pneumonitisSeminars in diagnostic pathology
researchProduct

Epidemiology of pneumococcal disease in children in Germany

2001

UNLABELLED Recently published and as yet unpublished data allow a reasonable estimate of the annual burden of pneumococcal disease in Germany. At least 277,000 episodes of otitis media and at least 2,000 episodes of sinusitis occur in children under the age of 5 y. Pneumococcal meningitis was found in 200 children under the age of 16 y; the estimate for all age groups ranges from 450 to 1100 cases. Of approximately 150,000 cases of ambulatory pneumococcal pneumonia, at least 63,000-105,000 patients are hospitalized each year. CONCLUSION Further studies of pneumococcal epidemiology in Germany are needed, and continued surveillance will be necessary for a better understanding of the overall b…

medicine.medical_specialtyPediatricsAdolescentPrevalencemedicine.disease_causePneumococcal InfectionsGermanyEpidemiologyStreptococcus pneumoniaemedicineHumansSerotypingSinusitisChildMeningitis Pneumococcalbusiness.industryData CollectionIncidenceIncidence (epidemiology)Bacterial pneumoniaGeneral Medicinemedicine.diseaseHospitalizationOtitis MediaStreptococcus pneumoniaeOtitisPopulation SurveillancePediatrics Perinatology and Child HealthPneumococcal pneumoniaImmunologymedicine.symptombusinessMeningitisActa Paediatrica
researchProduct

I06 Dysphagia In Huntington`s Disease: A Multicenter Study

2014

Background Dysphagia is a common complication of neurogenerative disorders, and a leading cause of death due to aspiration pneumonia. Little is known about the frequency and the characteristics of dysphagia in HD. Well-balanced strategies for treatment and prevention of dysphagia in HD are lacking. Objetives To determine the prevalence of dysphagia in HD. Methods National, multicenter, observational, cross-sectional Study (Spanish EHDN). Dysphagia was assessed using the questionnaire EAT-10 (eating assessment tool), caregiver burden using the SumaCare, functional capacity using the TFC score, disease severity using the Unified HD Rating Scale (UHDRS), psyquiatric status (PBA-s), nutritional…

medicine.medical_specialtyPediatricsbusiness.industryCaregiver burdenAspiration pneumoniamedicine.diseaseDysphagiaPsychiatry and Mental healthHuntington's diseaseQuality of lifeotorhinolaryngologic diseasesNursing Interventions ClassificationPhysical therapyMedicineSurgeryNeurology (clinical)medicine.symptombusinessBody mass indexCause of deathJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

Community acquired pneumonia in children: Treatment of complicated cases and risk patients. Consensus statement by the Spanish Society of Paediatric …

2015

The incidence of community-acquired pneumonia complications has increased during the last decade. According to the records from several countries, empyema and necrotising pneumonia became more frequent during the last few years. The optimal therapeutic approach for such conditions is still controversial. Both pharmacological management (antimicrobials and fibrinolysis), and surgical management (pleural drainage and video-assisted thoracoscopic surgery), are the subject of continuous assessment. In this paper, the Spanish Society of Paediatric Infectious Diseases and the Spanish Society of Paediatric Chest Diseases have reviewed the available evidence. Consensus treatment guidelines are prop…

medicine.medical_specialtyPleural effusionNeumonía adquirida en la comunidadPopulationDrenaje pleuralPediatricsRJ1-570Empiema pleuralTherapeutic approachCommunity-acquired pneumoniaManagement of Technology and InnovationmedicineeducationIntensive care medicineNiñosVideotoracoscopiaeducation.field_of_studybusiness.industryPleural empyemaIncidence (epidemiology)medicine.diseaseEmpyemarespiratory tract diseasesPneumoniaFibrinolíticosbusinessAnales de Pediatría (English Edition)
researchProduct

Differences between Community Acquired Legionnaire's Pneumonia (CAP-L) and Pneumococcal Pneumonia (CAP-P).

2009

medicine.medical_specialtyPneumoniabusiness.industryInternal medicinePneumococcal pneumoniamedicinemedicine.diseasebusinessA47. COMMUNITY ACQUIRED PNEUMONIA AND HEALTHCARE ASSOCIATED PNEUMONIA
researchProduct

Phenotypic Characteristics And Outcomes Of Early Pneumonia Diagnosis (within 24 Hours)

2011

medicine.medical_specialtyPneumoniabusiness.industryInternal medicinemedicinemedicine.diseasebusinessC55. RISK FACTORS, PROGNOSIS, AND MANAGEMENT OF BACTERIAL PNEUMONIA
researchProduct

Thrombosis

2014

Background— Thrombosis is the common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischemic heart disease and stroke collectively caused 1 in 4 deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. Objective— To review the literature on the global burden of disease caused by VTE. Approach and Results— We performed a systematic review of the literature on the global disease burden because of VTE in low-, middle-, and high-income countries. Studies from Western Europe, North America, Australia, and Southern Latin America (Argentina) yielded…

medicine.medical_specialtyPopulation ageingPopulationMyocardial IschemiaDisease030204 cardiovascular system & hematologyGlobal HealthCohort Studies03 medical and health sciencesLife Expectancy0302 clinical medicineCost of IllnessCause of DeathEnvironmental healthGlobal healthPrevalenceHumansMedicinecardiovascular diseases030212 general & internal medicineIntensive care medicineeducationStrokeDisease burdenCause of deathVenous Thrombosiseducation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)Racial GroupsAge FactorsThrombosisVenous ThromboembolismHematologymedicine.diseaseThrombosis3. Good healthStrokePneumoniaVenous thrombosisSocial ClassQuality-Adjusted Life YearsMedical emergencyPulmonary EmbolismCardiology and Cardiovascular MedicinebusinessArteriosclerosis, Thrombosis, and Vascular Biology
researchProduct

Coronavirus disease 2019 in chronic kidney disease

2020

Abstract The clinical spectrum of coronavirus disease 2019 (COVID-19) infection ranges from asymptomatic infection to severe pneumonia with respiratory failure and even death. More severe cases with higher mortality have been reported in older patients and in those with chronic illness such as hypertension, diabetes or cardiovascular diseases. In this regard, patients with chronic kidney disease (CKD) have a higher rate of all-type infections and cardiovascular disease than the general population. A markedly altered immune system and immunosuppressed state may predispose CKD patients to infectious complications. Likewise, they have a state of chronic systemic inflammation that may increase …

medicine.medical_specialtyPopulation030232 urology & nephrologyDiseaseurologic and male genital diseasesSystemic inflammationAsymptomaticlaw.invention03 medical and health sciences0302 clinical medicinecardiovascular diseaselawChronic kidney diseaseInternal medicineDiabetes mellitusmedicineeducationCKJ ReviewstherapyTransplantationeducation.field_of_studySARS-CoV-2business.industryImmunityCOVID-19Cardiovascular diseasemedicine.diseaseimmunityIntensive care unitVirusPneumoniaNephrologyTherapymedicine.symptombusinesschronic kidney diseaseKidney diseaseClinical Kidney Journal
researchProduct

Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 5…

2021

Introduction: Despite respiratory disease being a major cause of excess mortality in people with schizophrenia, the prevalence of respiratory conditions in this population is poorly defined. A systematic review and meta-analysis were conducted to establish the prevalence and association of respiratory diseases in people with schizophrenia. Material and methods: Major electronic databases were searched from inception to 27 April 2020 for articles reporting respiratory disease (asthma, chronic obstructive pulmonary disease [COPD], pneumonia, and tuberculosis) in people with schizophrenia and, where possible, a control group. A random-effects meta-analysis was conducted. The study was register…

medicine.medical_specialtyPopulationPulmonary Disease Chronic ObstructiveInternal medicinePrevalenceHumansMedicineeducationBiological PsychiatryAsthmaCOPDeducation.field_of_studybusiness.industryRespiratory diseasePneumoniaOdds ratiomedicine.diseaserespiratory diseaseAsthmaPsychiatry and Mental healthPneumoniaSchizophreniaLung diseaseMeta-analysisSchizophreniabusinessSchizophrenia Research
researchProduct